Results 241 to 250 of about 2,864,300 (339)

Excess Alcohol‐Induced Hospitalisations and Deaths During the First Year of the COVID‐19 Pandemic in Australia

open access: yesDrug and Alcohol Review, EarlyView.
ABSTRACT Introduction Since the onset of COVID‐19, alcohol‐related harm has increased in regions such as the United States and the United Kingdom. We examined whether alcohol‐related harm increased with the pandemic in Australia, and whether the impact varied across sex, age and type of alcohol diagnosis.
Wing See Yuen   +7 more
wiley   +1 more source

Comparison of Remimazolam and Propofol for Sedation in Endoscopic Retrograde Cholangiopancreatography: A Systematic Review and Meta‐Analysis With Trial Sequential Analysis

open access: yesDigestive Endoscopy, EarlyView.
This systematic review and meta‐analysis of 5 randomized controlled trials (n = 965) compares the safety profile of remimazolam versus propofol for sedation during ERCP. Remimazolam was associated with a significantly lower incidence of hypoxia, hypotension, and bradycardia.
In Jung Kim   +3 more
wiley   +1 more source

Atypical presentation of painless acute pancreatitis: A case report. [PDF]

open access: yesWorld J Clin Cases
Sargon K   +5 more
europepmc   +1 more source

Inhibitory effect of various cytostatics and cycloheximide on acute experimental pancreatitis in rats. [PDF]

open access: bronze, 1977
L Korbová   +6 more
openalex   +1 more source

Impact of a Thinner Snare Wire With Optimal Electrosurgical Unit Settings on the Risk of Delayed Bleeding After Endoscopic Papillectomy: A Propensity Score‐Matched Analysis (With Video)

open access: yesDigestive Endoscopy, EarlyView.
ABSTRACT Objectives The indications for endoscopic papillectomy (EP) have expanded. However, post‐procedural adverse events remain high. We performed ex vivo and clinical studies to determine the usefulness of a thinner snare wire (TSW) for preventing delayed bleeding after EP.
Kenjiro Yamamoto   +13 more
wiley   +1 more source

Tirzepatide and cardiometabolic parameters in obesity: Summary of current evidence

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Globally, cardiovascular diseases (CVDs) account for around one‐third of all deaths. Clinical trial evidence suggests that treatment of people with obesity or type 2 diabetes (T2D) and CVD with glucagon‐like peptide‐1 (GLP‐1) receptor agonists reduces the risk of major adverse cardiovascular events, heart failure outcomes and all‐cause ...
Naveed Sattar   +5 more
wiley   +1 more source

ACUTE PANCREATITIS

open access: bronze, 1963
P. B. Wets, S. A. Taheri
openalex   +1 more source

Home - About - Disclaimer - Privacy